Research News – May and June 2018
Catch up on the latest research news!
Research News – May and June 2018 Read More »
DRPLA
FDA Orphan Drug Designation for Spinocerebellar
IntraBio, a U.K. based biopharmaceutical company, has received an Orphan Drug Designation from the US Food and Drug Administration (FDA) for its lead compound (IB1000) for the treatment of spinocerebellar
FDA Orphan Drug Designation for Spinocerebellar Read More »
Latest Research News – December 2016
Read up on the latest research news!
Latest Research News – December 2016 Read More »
European Reference Networks
the European Commission approves the first 23 European Reference Networks for rare diseases (ERNs), including the one covering the ataxias.
European Reference Networks Read More »
Latest Research News – July and August 2016
Read up on the latest research news!
Latest Research News – July and August 2016 Read More »
